Skip to main content

Stefan Huemmer

Institutions of which they are part

Main researcher
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Stefan Huemmer

Institutions of which they are part

Main researcher
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Projects

inhibición de la comunicación celular para la prevención del desarrollo de metástasis y la resistencia a terapias antitumorales. Desarrollo de dos nuevas aproximaciones terapéuticas

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Maria Rosa Somoza Lopez de Haro, Josep Castellví Vives, Sara Garcia Ortega, Elena Muro Blanc, Marta Cano Galietero, Javier Hernandez Losa, Marta Sese Faustino, Stefan Hummer, Lourdes Elena Salazar Huayna
Funding agency: Instituto de Salud Carlos III
Funding: 240000
Reference: PI23/01754
Duration: 01/01/2024 - 31/12/2026

Targeting the polyglutamylation enzyme TTLL11 - a novel strategy for cancer therapy (MITOCANCER)

IP: Stefan Hummer
Collaborators: -
Funding agency: Fundació Institut Bioenginyeria de Catalunya
Funding: 0.01
Reference: IBEC/2022/ HUMMER
Duration: 02/01/2023 - 31/12/2024

MnkImmunOnco) - Overcoming therapy resistance and immune evasion with a novel MNK inhibibtor

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Inés de Torres Ramirez, Jordi Temprana Salvador, Vicente Peg Camara, Stefan Hummer
Funding agency: Fundació Institut Bioenginyeria de Catalunya
Funding: 0.01
Reference: M6871
Duration: 02/01/2023 - 31/12/2024

Patologia molecular translacional

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Cleofé Romagosa Pérez-Portabell, Maria Rosa Somoza Lopez de Haro, Jordi Temprana Salvador, Teresa Moline Marimon, Jessica Camacho Soriano, Carmela Iglesias i Felip, Josep Castellví Vives, Elena Muro Blanc, Marta Cano Galietero, Elena Antima Martinez Saez, Javier Hernandez Losa, Marta Sese Faustino, Vicente Peg Camara, Irene Sansano Valero, Trond Aasen, Stefan Hummer
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 40000
Reference: 2021 SGR 01138
Duration: 01/01/2022 - 30/06/2025

Related news

On World Cancer Research Day, we highlight the oncology research model of the Vall d'Hebron Campus that allows laboratory results to be transferred as quickly as possible to clinical practice.

Vall d’Hebron ha celebrat avui la Jornada del Dia Mundial contra el Càncer, una malaltia cada cop més freqüent que patiran al llarg de la vida un de cada dos homes i una de cada tres dones del nostre entorn.

The multidisciplinary paper on papillary thyroid cancer has been considered the best original article of 2021 in the journal Endocrinología, Diabetes y Nutrición

Related professionals

Joan Gavaldà Santapau

Joan Gavaldà Santapau

Main researcher
Infectious Diseases
Read more
Anna Jeanne Behr

Anna Jeanne Behr

Predoctoral researcher
Gene Therapy at Nervous System
Read more
Gemma Pujadas Rovira

Gemma Pujadas Rovira

Administration and Management
Read more
Renato Simonetti

Renato Simonetti

Predoctoral researcher
Stroke research
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.